Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
作者信息
Gupta Sarthak, Nakabo Shuichiro, Chu Jun, Hasni Sarfaraz, Kaplan Mariana J
机构信息
Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
Ann Rheum Dis. 2023 Oct;82(10):e215. doi: 10.1136/annrheumdis-2020-219648. Epub 2021 Jan 15.
Abstract
摘要
相似文献
1
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.关于“17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程”的通信
Ann Rheum Dis. 2023 Oct;82(10):e215. doi: 10.1136/annrheumdis-2020-219648. Epub 2021 Jan 15.
2
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.关于“17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程”的通信
Ann Rheum Dis. 2023 Nov;82(11):e225. doi: 10.1136/annrheumdis-2021-220410. Epub 2021 Apr 21.
3
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.关于“17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程”的通信
Ann Rheum Dis. 2021 Mar;80(3):e33. doi: 10.1136/annrheumdis-2020-217827. Epub 2020 May 29.
4
Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian .
Ann Rheum Dis. 2022 Nov;81(11):e216. doi: 10.1136/annrheumdis-2020-218778. Epub 2020 Aug 28.
5
Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon .对卡里永所著《长期接受羟氯喹治疗的系统性红斑狼疮患者的COVID-19临床病程》的回应
Ann Rheum Dis. 2021 Apr;80(4):e55. doi: 10.1136/annrheumdis-2020-217990. Epub 2020 May 31.
6
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour .对Nikpour所著《17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程》的回复
Ann Rheum Dis. 2021 Mar;80(3):e34. doi: 10.1136/annrheumdis-2020-217875. Epub 2020 May 29.
7
Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian ' by Notz .回复：“抗风湿药物、B细胞耗竭与重症COVID-19：关于Mathian等人‘17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程’的通信” 作者：诺茨
Ann Rheum Dis. 2022 Nov;81(11):e217. doi: 10.1136/annrheumdis-2020-218795. Epub 2020 Nov 25.
8
Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.长期接受羟氯喹治疗的系统性红斑狼疮患者的新型冠状病毒肺炎临床病程
Ann Rheum Dis. 2021 Apr;80(4):e54. doi: 10.1136/annrheumdis-2020-217847. Epub 2020 May 31.
9
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程
Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.
10
Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh .
Ann Rheum Dis. 2021 May;80(5):e70. doi: 10.1136/annrheumdis-2020-218173. Epub 2020 Jul 31.
引用本文的文献
1
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19.干扰素途径狼疮风险等位基因调节急性 COVID-19 死亡风险。
Transl Res. 2022 Jun;244:47-55. doi: 10.1016/j.trsl.2022.01.007. Epub 2022 Jan 31.
2
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year.COVID-19 大流行对系统性红斑狼疮患者的影响：一年随访研究
Clin Immunol. 2021 Oct;231:108845. doi: 10.1016/j.clim.2021.108845. Epub 2021 Aug 31.
本文引用的文献
1
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
2
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
3
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus.利用美国疫情中心提供红斑狼疮患者 COVID-19 的见解。
Arthritis Rheumatol. 2020 Dec;72(12):1971-1980. doi: 10.1002/art.41450. Epub 2020 Oct 28.
4
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程
Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.
5
Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.抗干扰素自身抗体在系统性红斑狼疮中的独特作用：常见风湿性疾病中细胞因子自身抗体的综合分析。
Arthritis Rheumatol. 2016 Jul;68(7):1677-87. doi: 10.1002/art.39607.
6
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.针对RAG缺陷中自身抗原和细胞因子的广谱抗体。
J Clin Invest. 2015 Nov 2;125(11):4135-48. doi: 10.1172/JCI80477. Epub 2015 Oct 12.
7
Interferons and viruses: an evolutionary arms race of molecular interactions.干扰素与病毒：分子相互作用的进化军备竞赛
Trends Immunol. 2015 Mar;36(3):124-38. doi: 10.1016/j.it.2015.01.004. Epub 2015 Feb 20.
8
Type I interferon in the pathogenesis of lupus.I 型干扰素在狼疮发病机制中的作用。
J Immunol. 2014 Jun 15;192(12):5459-68. doi: 10.4049/jimmunol.1002795.
Zotero 插件